You can now read 10 articles a month for free. Read as much as you want anywhere and anytime for just 99¢.

Mass. Movers

Parexel moves higher on analyst upgrade

Josef H. von Rickenbach is the CEO of Parexel.

Essdras M Suarez/Globe Staff/File

Josef H. von Rickenbach is the CEO of Parexel.

Continue reading below

Shares of Parexel International Corp. rose after the Waltham biopharmaceutical services company was upgraded by ISI Group from “neutral” to “buy” in a research note, according to TheFlyOnTheWall.com. The firm currently has a $57 price objective on the stock, up from $52.50. ISI Group’s target price indicates a potential upside of 14.73 percent from the stock’s previous close. In August, Parexel reported earnings per share of 50 cents for the quarter, beating estimates.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week